A recent survey by Celent reveals that by the end of 2023, half of insurers say that they’ll have tested generative AI (gen AI) solutions in the form …
ICYMI: Residents feel trapped and choked by dust, while experts warn environmental damage is ‘solving one problem by creating others’ Deep in the Mojave desert, about halfway between Los Angeles and Phoenix, a sparkling blue sea shimmers on the horizon. Visible from the I-10 highway, amid the parched … http://dlvr.it/SpRBvr
Exciting news from OpenAI! ChatGPT Plus subscribers will now have access to ChatGPT Plugins. This beta release allows for internet access and integration with over 70 third-party plugins. Read more about why this is a game-changer here: http://dlvr.it/Sp4PDY
WASHINGTON, April 8 (Reuters) - Synchron Inc, a rival to Elon Musk's Neuralink brain implant startup, is preparing to recruit patients for a large-scale clinical trial required to seek commercial approval for its device, the company's chief executive told Reuters. Synchron on Monday plans to launch … http://dlvr.it/T5GZqJ
Comments
Post a Comment